Literature DB >> 19562761

Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.

Kevin M Biglan1, Christopher A Ross, Douglas R Langbehn, Elizabeth H Aylward, Julie C Stout, Sarah Queller, Noelle E Carlozzi, Kevin Duff, Leigh J Beglinger, Jane S Paulsen.   

Abstract

The PREDICT-HD study seeks to identify clinical and biological markers of Huntington's disease in premanifest individuals who have undergone predictive genetic testing. We compared baseline motor data between gene-expansion carriers (cases) and nongene-expansion carriers (controls) using t-tests and Chi-square. Cases were categorized as near, mid, or far from diagnosis using a CAG-based formula. Striatal volumes were calculated using volumetric magnetic resonance imaging measurements. Multiple linear regression associated total motor score, motor domains, and individual motor items with estimated diagnosis and striatal volumes. Elevated total motor scores at baseline were associated with higher genetic probability of disease diagnosis in the near future (partial R(2) 0.14, P < 0.0001) and smaller striatal volumes (partial R(2) 0.15, P < 0.0001). Nearly all motor domain scores showed greater abnormality with increasing proximity to diagnosis, although bradykinesia and chorea were most highly associated with diagnostic immediacy. Among individual motor items, worse scores on finger tapping, tandem gait, Luria, saccade initiation, and chorea show unique association with diagnosis probability. Even in this premanifest population, subtle motor abnormalities were associated with a higher probability of disease diagnosis and smaller striatal volumes. Longitudinal assessment will help inform whether motor items will be useful measures in preventive clinical trials.

Entities:  

Mesh:

Year:  2009        PMID: 19562761      PMCID: PMC3048804          DOI: 10.1002/mds.22601

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  33 in total

1.  Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.

Authors:  H D Rosas; N D Hevelone; A K Zaleta; D N Greve; D H Salat; B Fischl
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  The eyes as a window into disease prevention.

Authors:  Kevin M Biglan; Michael Halmagyi
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Identification of an oculomotor biomarker of preclinical Huntington disease.

Authors:  C V P Golding; C Danchaivijitr; T L Hodgson; S J Tabrizi; C Kennard
Journal:  Neurology       Date:  2006-04-19       Impact factor: 9.910

4.  Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Authors:  C M Kipps; A J Duggins; N Mahant; L Gomes; J Ashburner; E A McCusker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

5.  Saccades in presymptomatic and early stages of Huntington disease.

Authors:  T Blekher; S A Johnson; J Marshall; K White; S Hui; M Weaver; J Gray; R Yee; J C Stout; X Beristain; J Wojcieszek; T Foroud
Journal:  Neurology       Date:  2006-07-19       Impact factor: 9.910

6.  Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.

Authors:  Sarah A J Reading; Michael A Yassa; Arnold Bakker; Adam C Dziorny; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; Elizabeth H Aylward; Jason Brandt; Susumu Mori; Peter van Zijl; Susan S Bassett; Christopher A Ross
Journal:  Psychiatry Res       Date:  2005-09-30       Impact factor: 3.222

7.  Preparing for preventive clinical trials: the Predict-HD study.

Authors:  Jane S Paulsen; Michael Hayden; Julie C Stout; Douglas R Langbehn; Elizabeth Aylward; Christopher A Ross; Mark Guttman; Martha Nance; Karl Kieburtz; David Oakes; Ira Shoulson; Elise Kayson; Shannon Johnson; Elizabeth Penziner
Journal:  Arch Neurol       Date:  2006-06

8.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.

Authors:  Jane S Paulsen; Janice L Zimbelman; Sean C Hinton; Douglas R Langbehn; Catherine L Leveroni; Michelle L Benjamin; Norman C Reynolds; Stephen M Rao
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

9.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

10.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154

View more
  62 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

2.  Couples' coping in prodromal Huntington disease: a mixed methods study.

Authors:  Nancy R Downing; Janet K Williams; Anne L Leserman; Jane S Paulsen
Journal:  J Genet Couns       Date:  2012-01-26       Impact factor: 2.537

Review 3.  The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.

Authors:  Ignacio Munoz-Sanjuan; Gillian P Bates
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

4.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

Review 5.  Young-onset dementia.

Authors:  Dulanji K Kuruppu; Brandy R Matthews
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

6.  Perceived stress in prodromal Huntington disease.

Authors:  Nancy Downing; Megan M Smith; Leigh J Beglinger; James Mills; Kevin Duff; Kelly C Rowe; Eric Epping; Jane S Paulsen
Journal:  Psychol Health       Date:  2011-06-21

7.  An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.

Authors:  Anthony L Vaccarino; Karen Anderson; Beth Borowsky; Kevin Duff; Joseph Giuliano; Mark Guttman; Aileen K Ho; Michael Orth; Jane S Paulsen; Terrence Sills; Daniel P van Kammen; Kenneth R Evans
Journal:  Mov Disord       Date:  2011-03-02       Impact factor: 10.338

8.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

9.  Monitoring Huntington's disease progression through preclinical and early stages.

Authors:  Chris Tang; Andrew Feigin
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 10.  Prospects for neuroprotective therapies in prodromal Huntington's disease.

Authors:  Abhishek Chandra; Ashu Johri; M Flint Beal
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.